Core Scientific, Inc. Common Stock (CORZ) — Cash Flow-to-Debt Ratio
Core Scientific, Inc. Common Stock (CORZ) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $249.88 Million could theoretically repay 0% of its total liabilities ($4.38 Billion) in one year. See how much free cash does Core Scientific, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Core Scientific, Inc. Common Stock Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Core Scientific, Inc. Common Stock across 7 annual periods. Also explore Core Scientific, Inc. Common Stock (CORZ) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Core Scientific, Inc. Common Stock (2019–2025)
Year-by-year debt coverage analysis for Core Scientific, Inc. Common Stock. For market capitalisation and broader financial context, see how much is Core Scientific, Inc. Common Stock worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $278.25 Million | $3.31 Billion | ▲ +374.0% |
| 2024 | 0.02x | $42.90 Million | $2.42 Billion | ▼ -64.3% |
| 2023 | 0.05x | $65.11 Million | $1.31 Billion | ▼ -70.5% |
| 2022 | 0.17x | $205.19 Million | $1.22 Billion | ▲ +426.2% |
| 2021 | -0.05x | $-56.73 Million | $1.10 Billion | ▲ +80.0% |
| 2020 | -0.26x | $-23.77 Million | $91.88 Million | ▼ -713.3% |
| 2019 | -0.03x | $-832.00K | $26.16 Million | — |